Neumora Therapeutics, Inc. (NMRA) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts NMRA Hot Sheet
Join SI Premium – FREE
Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q4 EPS of ($0.35), $0.12 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
